![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Friday, March 26, 2021 4:14:29 PM
If MDT owns 30% of the shares, they are still outstanding shares. They would effectively be paying themselves for those shares so they "get a refund" so to speak on the overall buyout price, but it does not discount the value of each share (including mine and yours)by 30%. It is still total buyout price divided by outstanding share count.
Message in reply to:
Everyone keeps valuing this robot with Medtronic like they don’t already own 30% of it. That will get subtracted off any BO offer. So again, $2 billion valuation minus 1/3 of IP already paid for by MDT comes down to $1.3 B and around nine bucks a share. Woo hoo.
If you were in the medical device industry and in hospitals you would realize that the intuitive SP robot makes up less than 5% of their capital and disposable business.
Robots that have sold for $3.5 B and up we’re robots that would handle the entire amount of indications for the procedures.
In other words, Auris doesn’t need a second robot to come in and handle the more complex indications. Same with the Mazor spine robot.
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM